Functional Aplasia of the Contralateral A1 Segment Influences Clinical Outcome in Patients with Occlusion of the Distal Internal Carotid Artery.

ICA occlusion acute ischemic stroke mechanical thrombectomy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
26 Feb 2022
Historique:
received: 27 01 2022
revised: 23 02 2022
accepted: 25 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Background: The importance of an A1 aplasia remains unclear in stroke patients. In this work, we analyze the impact of an A1 aplasia contralateral to an acute occlusion of the distal internal carotid artery (ICA) on clinical outcomes. Methods: We conducted a retrospective study of consecutive stroke patients treated with mechanical thrombectomy at 12 tertiary care centers between January 2015 and February 2021 due to an occlusion of the distal ICA. Functional A1 aplasia was defined as the absence of A1 or hypoplastic A1 (>50% reduction to the contralateral site). Functional independence was measured by the modified Rankin Scale (mRS ≤ 2). Results: In total, 81 out of 1068 (8%) patients had functional A1 aplasia contralateral to distal ICA occlusion. Patients with functional contralateral A1 aplasia were more severely affected on admission (median NIHSS 18, IQR 15−23 vs. 17, IQR 13−21; aOR: 0.672, 95% CI: 0.448−1.007, p = 0.054) and post-interventional ischemic damage was larger (median ASPECTS 5, IQR 1−7, vs. 6, IQR 3−8; aOR: 1.817, 95% CI: 1.184−2.789, p = 0.006). Infarction occurred more often within the ipsilateral ACA territory (20/76, 26% vs. 110/961, 11%; aOR: 2.482, 95% CI: 1.389−4.437, p = 0.002) and both ACA territories (8/76, 11% vs. 5/961, 1%; aOR: 17.968, 95% CI: 4.979−64.847, p ≤ 0.001). Functional contralateral A1 aplasia was associated with a lower rate of functional independence at discharge (6/81, 8% vs. 194/965, 20%; aOR: 2.579, 95% CI: 1.086−6.122, p = 0.032) and after 90 days (5/55, 9% vs. 170/723, 24%; aOR: 2.664, 95% CI: 1.031−6.883, p = 0.043). Conclusions: A functional A1 aplasia contralateral to a distal ICA occlusion is associated with a poorer clinical outcome.

Identifiants

pubmed: 35268383
pii: jcm11051293
doi: 10.3390/jcm11051293
pmc: PMC8911253
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

AJNR Am J Neuroradiol. 2017 Jul;38(7):1368-1371
pubmed: 28473346
Stroke. 2018 Jul;49(7):1669-1677
pubmed: 29880554
Stroke. 2002 Jul;33(7):1821-6
pubmed: 12105360
Radiographics. 2009 Jul-Aug;29(4):1027-43
pubmed: 19605654
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Neurointerv Surg. 2014 Mar;6(2):83-6
pubmed: 23390038
AJNR Am J Neuroradiol. 2016 Apr;37(4):673-8
pubmed: 26542233
Clin Neuroradiol. 2020 Mar;30(1):67-76
pubmed: 30426172
J Med Case Rep. 2008 Jun 02;2:188
pubmed: 18518991
J Stroke. 2016 May;18(2):179-86
pubmed: 26915505
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104590
pubmed: 31883780
Turk Neurosurg. 2019;29(2):151-158
pubmed: 29484629
Neurology. 2008 Jun 10;70(24 Pt 2):2386-93
pubmed: 18541871

Auteurs

Sebastian Fischer (S)

Institute of Diagnostic and Interventional Radiology, Neuroradiology and Nuclear Medicine, Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, 44892 Bochum, Germany.

Lukas Goertz (L)

Department of Diagnostic and Interventional Radiology, University Hospital Cologne, 50937 Cologne, Germany.

Charlotte S Weyland (CS)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

Ali Khanafer (A)

Neuroradiological Clinic, Klinikum Stuttgart, 70174 Stuttgart, Germany.

Christoph J Maurer (CJ)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, 86156 Augsburg, Germany.

Hanna Zimmermann (H)

Institute for Diagnostic and Interventional Neuroradiology, University Hospital München-Großhadern, 81377 Munich, Germany.

Thomas David Fischer (TD)

Institute for Diagnostic and Interventional Neuroradiology, University Hospital München-Großhadern, 81377 Munich, Germany.

Hanna Styczen (H)

Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany.

Benjamin Tan (B)

Division of Neurology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore 119077, Singapore.

Maria Alexandrou (M)

Department of Diagnostic and Interventional Neuroradiology, Klinikum Bremen-Mitte, 28211 Bremen, Germany.

Donald Lobsien (D)

Department of Diagnostic and Interventional Radiology and Neuroradiology, Helios General Hospital Erfurt, 99089 Erfurt, Germany.

Elmar Lobsien (E)

Department of Neurology, Helios General Hospital Erfurt, 99089 Erfurt, Germany.

Maximilian Thormann (M)

Department of Diagnostic and Interventional Radiology, University Hospital Magdeburg, 39120 Magdeburg, Germany.

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.

Nuran Abdullayev (N)

Department of Diagnostic and Interventional Radiology, University Hospital Cologne, 50937 Cologne, Germany.

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.

Anastasios Mpotsaris (A)

Department of Diagnostic and Interventional Radiology, University Hospital Magdeburg, 39120 Magdeburg, Germany.

Panagiotis Papanagiotou (P)

Department of Diagnostic and Interventional Neuroradiology, Klinikum Bremen-Mitte, 28211 Bremen, Germany.
Department of Radiology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 10679 Athens, Greece.

Leonard Yeo (L)

Division of Neurology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore 119077, Singapore.

Cornelius Deuschl (C)

Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany.

Thomas Liebig (T)

Institute for Diagnostic and Interventional Neuroradiology, University Hospital München-Großhadern, 81377 Munich, Germany.

Ansgar Berlis (A)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, 86156 Augsburg, Germany.

Hans Henkes (H)

Neuroradiological Clinic, Klinikum Stuttgart, 70174 Stuttgart, Germany.

Markus Möhlenbruch (M)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

Volker Maus (V)

Institute of Diagnostic and Interventional Radiology, Neuroradiology and Nuclear Medicine, Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, 44892 Bochum, Germany.

Classifications MeSH